col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


25 Ergebisse       Seite 1

 [1] 
Elsevier: Journal of Advanced Research
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―10 SARS-CoV-2 damages cardiomyocyte mitochondria and implicates long COVID-associated cardiovascular manifestations Wenliang Che, Shuai Guo, Yanqun Wang, Xiaohua Wan, Bingyu Tan, Hailing Li, et al. (+17)
2 [GO] 2025―Mai―09 Palmitoylated COX-2Cys555 reprogrammed mitochondrial metabolism in pyroptotic inflammatory injury in patients with post-acute COVID-19 syndrome Jia-Shen Wu, Chi-Yu Xu, Su-Min Mo, Xin-Mou Wu, Ze-Bang Du, Lin Che, et al. (+7)
3 [GO] 2024―Dez―11 Key β1-4 galactosylated glycan receptors of SARS-CoV-2 and its inhibitor from the galactosylated glycoproteins of bovine milk Hanjie Yu, Wentian Chen, Jian Shu, Xin Wu, Jia Quan, Hongwei Cheng, et al. (+4)
4 [GO] 2024―Nov―09 Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms Abbas F. Almulla, Michael Maes, Bo Zhou, Hussein K. Al-Hakeim, Aristo Vojdani
5 [GO] 2023―Nov―27 Harnessing peptide and nanoparticle technology for developing innovative vaccination strategy against COVID-19 Hassan Elsayed, Rehab Moustafa, Reem Fathy, Sherine N. Khattab, Mona M. Agwa, Eman Mahmoud, et al. (+11)
6 [GO] 2023―Nov―27 Challenges facing hepatitis B infected population during the COVID-19 crisis, how far are we? Mahmoud Essam, Abdelhamed A. Salem, Amany Ahmed Salem, Sherief Abd-Elsalam, Ossama Ashraf Ahmed, Amira Mahmoud Al Balakosy, et al. (+5)
7 [GO] 2023―Nov―27 Does angiotensin converting enzyme (ACE) receptor genetic polymorphism has a role in COVID-19 infection outcome? Mahmoud El-Bendary, Mustafa Naemattalah, Hatem Elalfy, Tarek Besheer, Ahmed Elhawary, Abdel-Hady El-Gilany, et al. (+3)
8 [GO] 2023―Nov―27 Association of Interleukin-6(IL-6) and IL-10 genetic polymorphism with the severity of COVID-19 patients Mahmoud El-Bendary, Mustafa Naemattalah, Hatem Elalfy, Tarek Besheer, Ahmed Elnakib, Ahmed Elhawary, et al. (+3)
9 [GO] 2023―Nov―27 Extra corporeal therapy in critically ill COVID-19 patients: Is it the savior? Samy Zaky, Mohamed Elbadry, Hoda A Makhlouf, Sherif Abd El-Salam, Tarik S. Sarhan, Noha H. Eltaweel, et al. (+8)
10 [GO] 2023―Okt―04 Alisol B 23-acetate broadly inhibits coronavirus through blocking virus entry and suppresses proinflammatory T cells responses for the treatment of COVID-19 Qiaohui Du, Ronghui Liang, Meiling Wu, Minxiao Yang, Yubin Xie, Qing Liu, et al. (+4)
11 [GO] 2023―Aug―08 Modifications of Lipid Pathways Restrict SARS-CoV-2 Propagation in Human Induced Pluripotent Stem Cell-derived 3D Airway Organoids Ping-Hsing Tsai, Jun-Ren Sun, Yueh Chien, Man Sheung Chan, Winnie Khor, Hsin-Chou Yang, et al. (+15)
12 [GO] 2023―Feb―25 Corrigendum to “Novel dynamic fuzzy Decision-Making framework for COVID-19 vaccine dose recipients” [J. Adv. Res. 37 (2022) 147-168] O.S. Albahri, A.A. Zaidan, A.S. Albahri, H.A. Alsattar, Rawia Mohammed, Uwe Aickelin, et al. (+8)
13 [GO] 2021―Nov―26 Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome Olga A. Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, SabbaRao V. Madhunapantula, Mikhail Sinelnikov, Vladimir N. Nikolenko, et al. (+5)
14 [GO] 2021―Nov―26 Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients Qing Lei, Cai-zheng Yu, Yang Li, Hong-yan Hou, Zhao-wei Xu, Zong-jie Yao, et al. (+19)
15 [GO] 2021―Nov―26 Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection Yang Yi, Junhua Li, Xinyuan Lai, Meng Zhang, Yi Kuang, Yang-Oujie Bao, et al. (+11)
16 [GO] 2021―Nov―16 The role of mild and asymptomatic infections on COVID-19 vaccines performance: a modeling study Maíra Aguiar, Joseba Bidaurrazaga Van-Dierdonck, Javier Mar, Nico Stollenwerk
17 [GO] 2021―Nov―09 Virucidal and biodegradable specialty cellulose nonwovens as personal protective equipment against COVID-19 pandemic Chao Deng, Farzad Seidi, Qiang Yong, Xiangyu Jin, Chengcheng Li, Ling Zheng, et al. (+2)
18 [GO] 2021―Aug―21 Novel Dynamic Fuzzy Decision-Making Framework for COVID-19 Vaccine Dose Recipients O.S. Albahri, A.A. Zaidan, A.S. Albahri, HA. Alsatta, R. Mohammed, Uwe Aickelin, et al. (+8)
19 [GO] 2021―Jul―27 Longitudinal and Proteome-wide Analyses of Antibodies in COVID-19 Patients Reveal Features of the Humoral Immune Response to SARS-CoV-2 Jianxin Wang, Yongfei Yang, Te Liang, Ning Yang, Tao Li, Chang Zheng, et al. (+21)
20 [GO] 2021―Jul―22 Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection Vijayakumar Jawalagatti, Perumalraja Kirthika, Ji-Young Park, Chamith Hewawaduge, John Hwa Lee
21 [GO] 2021―Jan―10 Recovery scenario and immunity in COVID-19 disease: a new strategy to predict the potential of reinfection Zahra Khoshkam, Younes Aftabi, Peter Stenvinkel, B. Paige Lawrence, Mehran Habibi Rezaei, Gaku Ichihara, Sasan Fereidouni
22 [GO] 2020―Nov―26 Genomic characterization of SARS-CoV-2 in Egypt Abdel-Rahman N. Zekri, Khaled Easa Amer, Mohammed M Hafez, Zeinab K. Hassan, Ola S Ahmed, Hany K. Soliman, et al. (+15)
23 [GO] 2020―Aug―25 A hybrid fractional optimal control for a novel Coronavirus (2019-nCov) mathematical model N.H. Sweilam, S.M. AL-Mekhlafi, D. Baleanu
24 [GO] 2020―Aug―06 Molecular diagnostic technologies for COVID-19: Limitations and challenges Adeel Afzal
25 [GO] 2020―Mrz―16 COVID-19 infection: origin, transmission, and characteristics of human coronaviruses Muhammad Adnan Shereen, Suliman Khan, Abeer Kazmi, Nadia Bashir, Rabeea Siddique
 [1] 

25 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec